Literature DB >> 3277608

Impact of vitamin A supplementation on xerophthalmia. A randomized controlled community trial.

E Djunaedi1, A Sommer, A Pandji, H R Taylor.   

Abstract

The value of biannual distribution of 200,000 IU of vitamin A in preventing xerophthalmia was assessed in a randomized, controlled community-based trial involving 25,000 preschool children in 450 villages of northern Sumatra. Results indicate that distribution was associated with a dramatic decline in xerophthalmia prevalence; that concurrent controls were critical for distinguishing spontaneous from program-related changes; and that the apparent level of benefit depended on the choice of clinical indicator(s). Night blindness ceases to be an accurate reflection of impact when prevalence rates are low, and comparison of Bitot's spot rates should be confined to new cases of disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277608     DOI: 10.1001/archopht.1988.01060130228033

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Determinants of community-based coverage: periodic vitamin A supplementation. Aceh Study Group.

Authors:  I Tarwotjo; K P West; L Mele; S Nur; H Nendrawati; D Kraushaar; R L Tilden
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

2.  Bitot-like spots in children with normal vitamin A levels.

Authors:  Anu Maudgil; Diyaa Rachdan; Muhammad Saad Khan; Amir Siddiqui; Lil-Naz Hazrati; Michael D Richards; Nasrin Najm-Tehrani; Asim Ali
Journal:  Eye (Lond)       Date:  2021-09-16       Impact factor: 4.456

Review 3.  Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.

Authors:  Aamer Imdad; Evan Mayo-Wilson; Maya R Haykal; Allison Regan; Jasleen Sidhu; Abigail Smith; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2022-03-16

4.  Xerophthalmia clinics in rural eye camps.

Authors:  N C Desai; S Desai; R Desai
Journal:  Int Ophthalmol       Date:  1992-05       Impact factor: 2.031

5.  Safety of one 52-mumol (50,000 IU) oral dose of vitamin A administered to neonates.

Authors:  T Agoestina; J H Humphrey; G A Taylor; A Usman; D Subardja; S Hidayat; M Nurachim; L Wu; D S Friedman; K P West
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 6.  Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.

Authors:  Aamer Imdad; Evan Mayo-Wilson; Kurt Herzer; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2017-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.